Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00302003 · BASELINE

Baseline characteristics

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma · Source last updated 2021-03-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      287
    units
    Participants
groups
  1. description
    Treatment consists of 3 cycles of Doxorubicin hydrochloride IV (25 mg/m2) days 1 \& 2, Vincristine sulfate IV (1.4 mg/m2 \[max 2.8 mg\]) Days 1 \& 8, Prednisone orally (40 mg/m2) Days 1-7, Cyclophosphamide IV (600 mg/m2) Days 1 \& 2, Filgrastim by mouth or IV (5 micrograms/kg/dose) 24 hours after Cyclophosphamide complete. See detailed description for remainder of therapy. radiation therapy: Undergo radiation therapy doxorubicin hydrochloride: Given IV vincristine sulfate: Given IV prednisone: Given orally cyclophosphamide: Given IV ifosfamide: Given IV vinorelbine tartrate: Given IV dexamethasone: Given IV etoposide phosphate: Given IV cisplatin: Given IV cytarabine: Given IV filgrastim: Given IV or subcutaneously
    id
    BG000
    title
    Doxorubicin, Vincristine, Cyclophosphamide and Filgrastim
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          272
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          15
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          3
          upper Limit
          21
          value
          15
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    Years
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          160
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          127
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          43
        title
        Hispanic or Latino
      2. measurements
        1. group Id
          BG000
          value
          227
        title
        Not Hispanic or Latino
      3. measurements
        1. group Id
          BG000
          value
          17
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Ethnicity (NIH/OMB)
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG000
          value
          8
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG000
          value
          29
        title
        Black or African American
      5. measurements
        1. group Id
          BG000
          value
          220
        title
        White
      6. measurements
        1. group Id
          BG000
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG000
          value
          27
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          250
      title
      United States
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Australia
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          25
      title
      Canada
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Israel
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Mexico
    6. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      New Zealand
    7. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Puerto Rico
    8. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Switzerland
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      287
    units
    Participants
groups
  1. description
    Treatment consists of 3 cycles of Doxorubicin hydrochloride IV (25 mg/m2) days 1 \& 2, Vincristine sulfate IV (1.4 mg/m2 \[max 2.8 mg\]) Days 1 \& 8, Prednisone orally (40 mg/m2) Days 1-7, Cyclophosphamide IV (600 mg/m2) Days 1 \& 2, Filgrastim by mouth or IV (5 micrograms/kg/dose) 24 hours after Cyclophosphamide complete. See detailed description for remainder of therapy. radiation therapy: Undergo radiation therapy doxorubicin hydrochloride: Given IV vincristine sulfate: Given IV prednisone: Given orally cyclophosphamide: Given IV ifosfamide: Given IV vinorelbine tartrate: Given IV dexamethasone: Given IV etoposide phosphate: Given IV cisplatin: Given IV cytarabine: Given IV filgrastim: Given IV or subcutaneously
    id
    BG000
    title
    Doxorubicin, Vincristine, Cyclophosphamide and Filgrastim
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          272
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          15
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          3
          upper Limit
          21
          value
          15
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    Years
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          160
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          127
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          43
        title
        Hispanic or Latino
      2. measurements
        1. group Id
          BG000
          value
          227
        title
        Not Hispanic or Latino
      3. measurements
        1. group Id
          BG000
          value
          17
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Ethnicity (NIH/OMB)
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG000
          value
          8
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG000
          value
          29
        title
        Black or African American
      5. measurements
        1. group Id
          BG000
          value
          220
        title
        White
      6. measurements
        1. group Id
          BG000
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG000
          value
          27
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          250
      title
      United States
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Australia
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          25
      title
      Canada
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Israel
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Mexico
    6. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      New Zealand
    7. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Puerto Rico
    8. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Switzerland
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice